The Role of Pull Incentives in Addressing Antim...

By HEOR Staff Writer

June 26, 2024

Introduction Antimicrobial resistance (AMR) is a growing global health threat. According to rece...
Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-...
The Shift to Value-Based Drug Pricing in the United States
Unlocking the Potential of Cell and Gene Therapies: A Path to Affordable Heal...
Strategies for Fair Drug Pricing: Balancing Pharmacy Viability and Cost Conta...
Sustainable Pricing in Diabetes: Cost-Effective Medication Access
Biosimilar Competition and Patient Out-of-Pocket Costs
Managing Access to Medicines in the Future: Innovations and Strategies
Economics in Clinical Trials: A Guide to Value-Based Decisions
Policy of Innovative Health Technology: Biobanks in Abu Dhabi
Evaluating the Cost-Effectiveness of Adebrelimab in ES-SCLC
Unlocking the Potential of Digital Twins in Healthcare
Cost-effective Treatment: A Closer Look at SGLT2 Inhibitors